Lotus Pharmaceutical Co Ltd (1795):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Lotus Pharmaceutical Co Ltd (1795) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8065
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Lotus Pharmaceutical Co Ltd (Lotus Pharmaceutical), a subsidiary of Alvogen Inc is a pharmaceutical company that develops and sells pharmaceutical products. The company provides products that are used in the treatment of rheumatology, cancer, cardiology, dyslipidemia, hypertension, woman healthcare, oncology, gastrointestinal, auto immune, nephrology, and central nervous systems, among others. It offers services such as research and development, contract manufacturing, and contract research services. Lotus Pharmaceutical also provides biosimilars, an alternative to existing biological medicinal products. The company exports its products to Japan and South Korea. It has its operations in India, South Korea, Malaysia, China, Vietnam, Hong Kong, Thailand, Myanmar and the Philippines. Lotus Pharmaceutical is headquartered in Taipei, Taiwan.

Lotus Pharmaceutical Co Ltd (1795) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Lotus Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lotus Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lotus Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lotus Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Lotus Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Lotus Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Lotus Pharma Acquires Osteoporosis from Novartis 10
Partnerships 11
Lotus Pharma, Tzu Chi Hospital and EF Biotech to Enter into Agreement 11
Licensing Agreements 12
Luye Pharma Enters into Licensing Agreement with Lotus Pharma 12
Asset Transactions 13
Lotus Pharma Plans to Sell Product Rights 13
Acquisition 14
Alvogen To Acquire 67% Stake In Lotus Pharma For US$205 Million 14
Lotus Pharmaceutical Co Ltd – Key Competitors 15
Lotus Pharmaceutical Co Ltd – Key Employees 16
Lotus Pharmaceutical Co Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Corporate Communications 18
Jan 16, 2018: Lotus Enters Management Team Integration With Alvogen – Petar Vazharov Steps Up As Lotus General Manager 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Lotus Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Lotus Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lotus Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lotus Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lotus Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Lotus Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Lotus Pharma Acquires Osteoporosis from Novartis 10
Lotus Pharma, Tzu Chi Hospital and EF Biotech to Enter into Agreement 11
Luye Pharma Enters into Licensing Agreement with Lotus Pharma 12
Lotus Pharma Plans to Sell Product Rights 13
Alvogen To Acquire 67% Stake In Lotus Pharma For US$205 Million 14
Lotus Pharmaceutical Co Ltd, Key Competitors 15
Lotus Pharmaceutical Co Ltd, Key Employees 16
Lotus Pharmaceutical Co Ltd, Other Locations 17
Lotus Pharmaceutical Co Ltd, Subsidiaries 17

List of Figures
Lotus Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Lotus Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Lotus Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Lotus Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Lotus Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lotus Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Lotus Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lotus Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Lotus Pharmaceutical Co Ltd (1795):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SOSINA Exploration Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Sosina Exploration Ltd (Sosina), formerly Odegaard UK Ltd is an oil and gas company that offers exploration and development services. The company identifies probable oil and gas accumulations in co-operation with partners within the oil and gas industries. It provides services in geological …
  • Galliford Try Holdings Plc (GFRD):企業の財務・戦略的SWOT分析
    Galliford Try Holdings Plc (GFRD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Southern California Edison Co:発電所・企業SWOT分析
    Southern California Edison Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Brookfield Property REIT Inc (BPYU):企業の財務・戦略的SWOT分析
    Brookfield Property REIT Inc (BPYU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Deluxe Corporation (DLX):企業の財務・戦略的SWOT分析
    Deluxe Corporation (DLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • PICC Property and Casualty Company Limited:戦略・SWOT・企業財務分析
    PICC Property and Casualty Company Limited - Strategy, SWOT and Corporate Finance Report Summary PICC Property and Casualty Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Acme United Corporation:企業の戦略・SWOT・財務情報
    Acme United Corporation - Strategy, SWOT and Corporate Finance Report Summary Acme United Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • TSI Holdings Co., Ltd.:企業の戦略・SWOT・財務情報
    TSI Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary TSI Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Senomyx Inc (SNMX):企業の財務・戦略的SWOT分析
    Summary Senomyx Inc (Senomyx) focuses on the discovery, development and commercialization of novel flavor ingredients and natural high intensity sweeteners (HIS) to packaged food, beverage and ingredient supply industries. The company discovers and develops novel flavor ingredients and natural HIS t …
  • Wellcome Trust Sanger Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Wellcome Trust Sanger Institute (Sanger Institute) a subsidiary of Genome Research Ltd is a genomic discovery and research centre that carries out research and development in the areas of cellular and human genetics and infection genomics. It also provides postgraduate training on research a …
  • Valora Holding AG (VALN):企業の財務・戦略的SWOT分析
    Valora Holding AG (VALN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Telefonaktiebolaget LM Ericsson (ERIC B):企業の財務・戦略的SWOT分析
    Telefonaktiebolaget LM Ericsson (ERIC B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Asure Software, Inc. (ASUR):企業の財務・戦略的SWOT分析
    Asure Software, Inc. (ASUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • ECA S.A.:企業の戦略・SWOT・財務情報
    ECA S.A. - Strategy, SWOT and Corporate Finance Report Summary ECA S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Catholic Health Initiatives:企業の戦略・SWOT・財務情報
    Catholic Health Initiatives - Strategy, SWOT and Corporate Finance Report Summary Catholic Health Initiatives - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • YTL Power International Berhad:発電所・企業SWOT分析
    YTL Power International Berhad – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on ke …
  • Urigen Pharmaceuticals Inc:企業の戦略的SWOT分析
    Urigen Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Groupe Galeries Lafayette:戦略・SWOT・企業財務分析
    Groupe Galeries Lafayette - Strategy, SWOT and Corporate Finance Report Summary Groupe Galeries Lafayette - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Gamma Solutions SL-エネルギー分野:企業M&A・提携分析
    Summary Gamma Solutions SL (Gamma Solutions) is an engineering and consulting company that operates through energy, telecommunication, mobile and IT, and research and development divisions. The company offers products such as gamma start city monitoring system, photovoltaic rooftop monitoring system …
  • Whitehead Institute for Biomedical Research-製薬・医療分野:企業M&A・提携分析
    Summary Whitehead Institute for Biomedical Research (Whitehead Institute), a subsidiary of Massachusetts Institute of Technology is a non-profit research and educational institute that offers technologies to improve human health. The institute undertakes the development of therapies for diseases tha …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆